H Tomioka

Author PubWeight™ 9.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method. Antimicrob Agents Chemother 1993 1.24
2 The role of tumor necrosis factor, interferon-gamma, transforming growth factor-beta, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by Mycobacterium avium complex infection. J Leukoc Biol 1995 1.14
3 Characteristics of immunosuppressive macrophages induced in spleen cells by Mycobacterium avium complex infections in mice. J Gen Microbiol 1990 1.10
4 Characterization of immunosuppressive functions of murine peritoneal macrophages induced with various agents. J Leukoc Biol 1992 0.89
5 Effects of benzoxazinorifamycin KRM-1648 on cytokine production at sites of Mycobacterium avium complex infection induced in mice. Antimicrob Agents Chemother 1997 0.87
6 [Antimycobacterial activities of a new quinolone, sparfloxacin]. Kekkaku 1991 0.84
7 Comparative in vitro and in vivo activity of fleroxacin and ofloxacin against various mycobacteria. Tubercle 1991 0.84
8 Arylsulfatase activity for differentiating Mycobacterium avium and Mycobacterium intracellulare. J Clin Microbiol 1990 0.83
9 Comparison of the virulence for mice of Mycobacterium avium and Mycobacterium intracellulare identified by DNA probe test. Microbiol Immunol 1993 0.82
10 [Behaviour of gamma delta TCR+ T cells during the course of nontuberculous mycobacterial infections and proliferative response of host lymphocytes to 65kD heat shock protein]. Kekkaku 1993 0.76
11 [Attempts to elucidate reasons why mycobacterial infections are intractable, by using an experimental mouse infection model]. Nihon Hansenbyo Gakkai Zasshi 1996 0.75
12 [Expectation of new antituberculous drugs and targeting therapy for treatment of mycobacterial infections]. Kekkaku 1993 0.75
13 [Nontuberculous mycobacteriosis; the present status and in the future. Mechanisms of host resistance to Mycobacterium avium complex and Mycobacterium tuberculosis infection]. Kekkaku 1998 0.75
14 [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice]. Kekkaku 1993 0.75
15 Phospholipids of Mycobacterium intracellulare inhibit T cell blastogenesis. Microbiology 1994 0.75
16 Suppressive activity of splenic macrophages induced by transparent and opaque colonial variants of Mycobacterium avium complex against lymphoproliferative response. Microbiol Immunol 1993 0.75
17 [Commemorative lecture of receiving Imamura Memorial Prize. Characterization of immunosuppressive macrophages induced in mice infected with Mycobacterium intracellulare]. Kekkaku 1993 0.75
18 [Study of detailed conditions in DNA probe test by use of Gen-Probe Rapid Diagnostic System for identification of Mycobacterium avium complex and Mycobacterium tuberculosis complex]. Kekkaku 1991 0.75
19 [Antimicrobial activity of new quinolones against Mycobacterium avium and Mycobacterium intracellulare determined by the dilution methods using 7H11 agar and Ogawa egg media]. Kekkaku 1993 0.75
20 [Identification of Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium tuberculosis complex by Gen-Probe Rapid Diagnostic System]. Kekkaku 1991 0.75
21 [Reactivities of various mycobacteria species against DNA probes (Gen-Probe Rapid Diagnostic System) specific to Mycobacterium tuberculosis complex, Mycobacterium avium and Mycobacterium intracellulare]. Kekkaku 1991 0.75